Prism Research Group — Rome, Georgia

Prism Research Group is a clinical research site located in Rome, Georgia, United States 30165.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Prism Research Group has participated in 3 clinical trials.

Therapeutic areas: Orthostatic Hypotension, Parkinson's Disease, Urinary Bladder, Overactive.

Sponsors: Chelsea Therapeutics, Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rome

Browse all research sites in Georgia · View every site in Rome

• Redmond Regional Hospital
• Harbin Clinic Medical Oncology and Clinical Research
• Regional Radiation Oncology Center at Rome
• Harbin Clinic Cancer Center - Medical Oncology
• Harbin Clinic
• Redmond Regional Medical Center
• InterCommunity Cancer Center at Rome
• GSK Investigational Site
• Research Site
• Local Institution
• Valley Health Care

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prism Research Group?

Prism Research Group has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prism Research Group conducted?

Prism Research Group has 3 clinical trials on record. Their work covers Orthostatic Hypotension, Parkinson's Disease, Urinary Bladder, Overactive.

Is Prism Research Group accredited by Crixeo Clinical Trials?

Prism Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prism Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.